2011
204 Steroid-Free Immunosuppression after Routine Alemtuzumab Induction in Cardiac Transplantation: Three Year Outcomes
Teuteberg J, Zomak R, Navoney M, Bermudez C, Bonde P, Bhama J, Kormos R, McNamara D, Toyoda Y, Shullo M. 204 Steroid-Free Immunosuppression after Routine Alemtuzumab Induction in Cardiac Transplantation: Three Year Outcomes. The Journal Of Heart And Lung Transplantation 2011, 30: s74-s75. DOI: 10.1016/j.healun.2011.01.211.Peer-Reviewed Original Research645 Respiratory Failure While on Ventricular Assist Device (VAD) Support Has Persistent Consequences after Cardiac Transplantation
Genovese E, Dew M, Teuteberg J, Simon M, Bhama J, Bonde P, Bermudez C, Toyoda Y, McNamara D, Winowich S, Lockard K, Kormos R. 645 Respiratory Failure While on Ventricular Assist Device (VAD) Support Has Persistent Consequences after Cardiac Transplantation. The Journal Of Heart And Lung Transplantation 2011, 30: s214-s215. DOI: 10.1016/j.healun.2011.01.658.Peer-Reviewed Original Research
2006
Oxidative DNA damage and DNA mismatch repair pathway play an important role in failing human myocardium
Lin R, Gao D, Gu Y, Bonde P, Fitton T, Hare J, Conte J, Williams G, Wei C. Oxidative DNA damage and DNA mismatch repair pathway play an important role in failing human myocardium. Journal Of Cardiothoracic-Renal Research 2006, 1: 41-49. DOI: 10.1016/j.jccr.2005.11.004.Peer-Reviewed Original ResearchApoptosis-related genesDNA damageRepair enzymesDNA mismatch repair pathwayImmunohistochemical stainingHuman myocardiumMismatch repair pathwayCaspase-3Donor subjectsDNA repair enzymeProtein levelsHearts of patientsDNA reconstructionRepair pathwaysOxidative DNA damageLevel of apoptosisCHF myocardiumCardiac transplantationCHF patientsBackgroundHeart failureMyocardial failureResultsThe levelsEpidemic proportionsImportant roleMyocardium